Arterial infusion chemotherapy concurrent with radiation therapy followed by systemic gemcitabine and cisplatin therapy for unresectable biliary tract cancer patients; A phase2 study
Phase 2
- Conditions
- Biliary tract cancer
- Registration Number
- JPRN-UMIN000023906
- Lead Sponsor
- Asahikwa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Resectable biliary tract cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate, disease control rate, adverse events rate
- Secondary Outcome Measures
Name Time Method Median survival, protocol treatment completion rate, CA19-9 response rate, progression-free survival, distant metastasis-free survival, 1-year survival rate, 2-year survival rate